tirzepatide weight loss study UC Irvine researchers project cardiac benefits from weight-loss medication Body weight loss with tirzepatide

Under IRS rules, weight-loss treatment can qualify as an HSA- or FSA-eligible medical expense when it is prescribed for a specific diagnosed condition obesity, type 2 diabetes, hypertension, dyslipidemia, or cardiovascular disease rather than for general wellness or cosmetic weight loss

False, it brightens and evens the skin tone but does NOT change your natural genetic color

WASHINGTON Glucagon-like peptide-1 receptor agonists significantly reduced alanine aminotransferase levels in pediatric metabolic dysfunction-associated steatotic liver disease, especially those with type 2 diabetes, researchers reported

Reexposure to nicotine during withdrawal increases the pacemaking activity of cholinergic habenular neurons